Rivian

Wall Street analyst calls for major public companies

A CNBC roundup published on 2026-07-27 lists notable analyst actions and rating changes across many public companies. Highlights include Piper Sandler upgrading Rivian and Mobileye to overweight, Piper initiating Williams‑Sonoma as overweight with a $253 price target, UBS initiating coverage of marketing‑tech company ITG with a Buy and $18 target, Goldman Sachs reiterating Apple as a Buy and raising its 12‑month target to $370, and Bernstein reiterating Nvidia as Outperform. The piece compiles initiations, upgrades, downgrades and price‑target actions from firms such as JPMorgan, Jefferies, Barclays, Wells Fargo, Citi and others across sectors including autos, semiconductors, biotech, and media/marketing technology.

Understanding the Debate Over 'AI Psychosis'

TechCrunch examined a thread sparked by Box founder Aaron Levie, who suggested tech CEOs may be "uniquely prone to AI psychosis," during an episode of TechCrunch’s Equity podcast. Hosts Anthony Ha, Kirsten Korosec and Sean O'Kane discussed Levie’s point that executives should actually use AI tools to understand their limits, and explored a broader anti-AI moment among users and workers. The conversation referenced Google’s push to add more AI to search and early backlash — including a reported 30% increase in DuckDuckGo installs — plus industry layoffs and shifting workforce dynamics as companies adopt AI. The episode framed the tension between product-brand expectations (e.g., Google as an information retrieval system) and commercial AI features, and considered whether the moment creates openings for startups or alternative services.

Cerebras Prices IPO Above Expected Range

Cerebras Systems priced its initial public offering at $185 per share on May 13, 2026, raising at least $5.55 billion and achieving a fully diluted valuation of about $56.4 billion. The AI-chip maker — founded in 2016 and headquartered in Silicon Valley — will trade under the ticker CBRS. CEO and co‑founder Andrew Feldman holds an estimated $1.9 billion stake at the IPO price. The company has shifted toward offering cloud services built on its wafer‑scale chips and has an OpenAI contract reportedly worth over $20 billion for 750 megawatts of compute capacity. Cerebras reduced revenue concentration from a single customer (G42) after a previously withdrawn IPO attempt; the refreshed prospectus said G42 accounted for 24% of revenue last year while Mohamed bin Zayed University of Artificial Intelligence accounted for 62% of revenue. The deal is one of the largest U.S. tech IPOs in recent years.